|
Volumn 20, Issue 4, 2006, Pages 724-
|
Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: Lack of association with incidence, disease stage and progression-free survival [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD38 ANTIGEN;
PROTEIN BAX;
PROTEIN KINASE ZAP 70;
AGE;
BLOOD SAMPLING;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER RISK;
CANCER STAGING;
CANCER SURVIVAL;
CANCER SUSCEPTIBILITY;
CHRONIC LYMPHATIC LEUKEMIA;
CONTROLLED STUDY;
CYTOGENETICS;
DISEASE FREE SURVIVAL;
DISEASE MARKER;
FOLLOW UP;
GENE EXPRESSION REGULATION;
GENE FREQUENCY;
GENETIC ASSOCIATION;
GENETIC POLYMORPHISM;
GENETIC SUSCEPTIBILITY;
GENOTYPE;
HUMAN;
INCIDENCE;
LETTER;
MAJOR CLINICAL STUDY;
OVERALL SURVIVAL;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROMOTER REGION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RESTRICTION MAPPING;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SINGLE NUCLEOTIDE POLYMORPHISM;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT OUTCOME;
|
EID: 33646493520
PISSN: 08876924
EISSN: 14765551
Source Type: Journal
DOI: 10.1038/sj.leu.2404126 Document Type: Letter |
Times cited : (13)
|
References (4)
|